Globe Life (NYSE:GL) CEO Sells $9,121,500.00 in Stock

Globe Life Inc. (NYSE:GL) CEO James Matthew Darden sold 50,000 shares of the company’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $182.43, for a total value of $9,121,500.00. Following the completion of the transaction, the chief executive officer directly owned 58,451 shares in the company, valued at approximately $10,663,215.93. This represents a 46.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Globe Life Stock Performance

GL stock traded up $2.12 during trading hours on Monday, hitting $184.37. 655,003 shares of the stock were exchanged, compared to its average volume of 569,733. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $14.32 billion, a P/E ratio of 12.24 and a beta of 0.47. The company has a 50-day simple moving average of $171.52 and a two-hundred day simple moving average of $154.34.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the firm posted $3.05 EPS. The company’s revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, analysts forecast that Globe Life Inc. will post 15.7 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on GL shares. Truist Financial boosted their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Wells Fargo & Company boosted their price target on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Morgan Stanley increased their price target on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Finally, TD Cowen raised their price objective on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $191.67.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in shares of Globe Life by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after purchasing an additional 86,349 shares during the last quarter. Invesco Ltd. increased its position in Globe Life by 2.7% during the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after purchasing an additional 102,445 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Globe Life by 10.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock valued at $327,479,000 after purchasing an additional 217,331 shares during the last quarter. Morgan Stanley lifted its stake in Globe Life by 7.2% in the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after purchasing an additional 125,567 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in Globe Life by 32.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after buying an additional 355,399 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.